CLINICAL_TRIALS
trial_result
· 2026-06-25
Clinical Trial Results: Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke [Phase 3]
Summary
Phase 3 trial results evaluating evolocumab in high cardiovascular risk patients without prior myocardial infarction or stroke.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Coronary Heart Disease (CHD) | Phase 3 | Status: COMPLETED | Results posted: 2026-06-25